COVID-19 and (hydroxy)chloroquine-Azithromycin combination: Should we take the risk for our patients?

6 mai 2020

Source : ORCID

Auteur : H. Javelot et al.

Letter to editor :

The coronavirus disease 2019 (COVID-19) pandemic has caught the scientific community and hospitals off-guard and the race is on as clinicians grapple with novel treatment strategies and constantly changing recommendations. Patients with mental health disorders are particularly vulnerable to the coronavirus outbreak for various reasons, including cognitive impairment, little awareness of risk, diminished efforts regarding personal protection, and more barriers in accessing timely health services.


Télécharger l’article complet

© Les Hôpitaux Universitaires de Strasbourg 2020 - Tous droits réservés